AstraZeneca Reveals Treatment Plus Chemotherapy Reduced Disease Progression by 38% for Advanced NSCLC Patients in FLAURA2 Phase III Trial
Arun Krishna, VP, Head of Lung Cancer Franchise, US Oncology Business Unit at AstraZeneca discusses the positive results from the FLAURA2 Phase III trial of TAGRISSO ® (osimertinib) plus chemotherapy and its significance as a new potential treatment option for patients with advanced lung cancer.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Cancer?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Arun Krishna, Vice President, Head of Lung Cancer Franchise, US Oncology Business Unit, is responsible for overseeing all lung cancer US sales and the commercialization of TAGRISSO and future lung cancer indications.
Prior Experience
Before assuming his current role in 2022, Arun was the Head of Oncology in the UK where he led an integrated team across Commercial, Medical, Access, Diagnostics & Business Innovation in five therapeutic areas. Prior to joining AstraZeneca in 2019 he held various clinical development, new product strategy and market access roles at Novartis and Merck.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
